| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |